semaglutide and ibd GLP-1 obesity "inflammatory bowel disease" The bi-directional relationship between inflammatory

Semaglutide, marketed under the brand name Ozempic for diabetes and Wegovy for weight loss, is a once-weekly injectable medication already approved by the FDA for weight management

Tirzepatide May Be a Better Fit If: Maximum weight loss is your primary goal, and tirzepatide consistently produces greater reductions in clinical data You have type 2 diabetes and want superior blood sugar control (SURPASS-2 showed clear superiority over semaglutide) You've tried semaglutide and plateaued, and the dual-agonist mechanism may produce additional response You respond well to lower doses, and tirzepatide 5mg matches semaglutide 2.4mg for weight loss Semaglutide May Be a Better Fit If: Cardiovascular protection is important, as the SELECT trial provides strong evidence for heart benefit You prefer an oral option: oral semaglutide exists (the Ozempic pill for diabetes, which reformulated and renamed Rybelsus in 2026, and the Wegovy pill for weight)

The relationship between rapid glucose lowering and retinal complications is not new

Credentials: Board-certified Family Nurse Practitioner (FNP-BC) 10+ years of advanced practice nursing Licensed in the state of Florida Specializations: weight management, hormone therapy, urgent care, preventive medicine When You'll Visit Our Sanibel Office Most of your medical weight loss care happens virtually

GLP-1 and GIP are incretin hormones that stimulate insulin secretion after an oral glucose load by binding GLP-1R, but both are rapidly inactivated by the enzyme dipeptidyl peptidase-4 (DPP-4)

Artificial Sweeteners and Their Impact on Health Laura Goldman, Registered Dietitian, Registered Dietitian Are artificial sweeteners a healthier alternative to sugar when it comes to weight loss, or do they come with hidden drawbacks